155 related articles for article (PubMed ID: 19540427)
1. Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery.
Chen M; Li XR; Zhou YX; Yang KW; Chen XW; Deng Q; Liu Y; Ren LJ
Peptides; 2009 Jul; 30(7):1288-95. PubMed ID: 19540427
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of gelatin microspheres for nasal and intramuscular administrations of salmon calcitonin.
Morimoto K; Katsumata H; Yabuta T; Iwanaga K; Kakemi M; Tabata Y; Ikada Y
Eur J Pharm Sci; 2001 May; 13(2):179-85. PubMed ID: 11297902
[TBL] [Abstract][Full Text] [Related]
3. [The hypocalcemia effect of salmon calcitonin ultra-flexible liposomes after intranasal administration in rats].
Chen M; Deng Q; Li XR; Liu Y
Yao Xue Xue Bao; 2007 Jun; 42(6):681-6. PubMed ID: 17702409
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.
du Plessis LH; Lubbe J; Strauss T; Kotzé AF
Int J Pharm; 2010 Jan; 385(1-2):181-6. PubMed ID: 19854253
[TBL] [Abstract][Full Text] [Related]
5. Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep.
Hinchcliffe M; Jabbal-Gill I; Smith A
J Pharm Pharmacol; 2005 Jun; 57(6):681-7. PubMed ID: 15969922
[TBL] [Abstract][Full Text] [Related]
6. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
7. Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effects in rats.
Lee KC; Park MO; Na DH; Youn YS; Lee SD; Yoo SD; Lee HS; DeLuca PP
Calcif Tissue Int; 2003 Dec; 73(6):545-9. PubMed ID: 14508623
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of nasal absorption of calcitonin loaded in liposomes.
Law SL; Huang KJ; Chou VH; Cherng JY
J Liposome Res; 2001; 11(2-3):165-74. PubMed ID: 19530931
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
[TBL] [Abstract][Full Text] [Related]
10. Hypocalcemic effect of salmon calcitonin following single and repeated nasal and intravenous administration in young rabbits.
Schipper NG; Romeijn SG; Verhoef J; Merkus FW
Calcif Tissue Int; 1994 Jan; 54(1):50-5. PubMed ID: 8118754
[TBL] [Abstract][Full Text] [Related]
11. Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats.
Gradauer K; Barthelmes J; Vonach C; Almer G; Mangge H; Teubl B; Roblegg E; Dünnhaupt S; Fröhlich E; Bernkop-Schnürch A; Prassl R
J Control Release; 2013 Dec; 172(3):872-8. PubMed ID: 24140721
[TBL] [Abstract][Full Text] [Related]
12. Characterization of calcitonin-containing liposome formulations for intranasal delivery.
Law SL; Shih CL
J Microencapsul; 2001; 18(2):211-21. PubMed ID: 11253938
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
Garcia-Fuentes M; Prego C; Torres D; Alonso MJ
Eur J Pharm Sci; 2005 May; 25(1):133-43. PubMed ID: 15854809
[TBL] [Abstract][Full Text] [Related]
14. Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes.
Cho W; Kim MS; Jung MS; Park J; Cha KH; Kim JS; Park HJ; Alhalaweh A; Velaga SP; Hwang SJ
Int J Pharm; 2015 Jan; 478(1):288-296. PubMed ID: 25445994
[TBL] [Abstract][Full Text] [Related]
15. Improved intestinal delivery of salmon calcitonin by Lys18-amine specific PEGylation: stability, permeability, pharmacokinetic behavior and in vivo hypocalcemic efficacy.
Youn YS; Jung JY; Oh SH; Yoo SD; Lee KC
J Control Release; 2006 Sep; 114(3):334-42. PubMed ID: 16884808
[TBL] [Abstract][Full Text] [Related]
16. Methylated beta-cyclodextrins are able to improve the nasal absorption of salmon calcitonin.
Schipper NG; Verhoef JC; Romeijn SG; Merkus FW
Calcif Tissue Int; 1995 Apr; 56(4):280-2. PubMed ID: 7767838
[TBL] [Abstract][Full Text] [Related]
17. Potentiality of double liposomes containing salmon calcitonin as an oral dosage form.
Yamabe K; Kato Y; Onishi H; Machida Y
J Control Release; 2003 May; 89(3):429-36. PubMed ID: 12737845
[TBL] [Abstract][Full Text] [Related]
18. Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: optimization by PEG size selection.
Youn YS; Kwon MJ; Na DH; Chae SY; Lee S; Lee KC
J Control Release; 2008 Jan; 125(1):68-75. PubMed ID: 18023905
[TBL] [Abstract][Full Text] [Related]
19. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts.
Song KH; Chung SJ; Shim CK
J Control Release; 2005 Sep; 106(3):298-308. PubMed ID: 15979756
[TBL] [Abstract][Full Text] [Related]
20. The influence of the enhancer dimyristoylphosphatidylglycerol and formulation factors on the nasal absorption of salmon calcitonin.
Dua R; Duncan M; Zia H; Needham TE
Drug Deliv; 1998; 5(2):127-34. PubMed ID: 19570004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
